9 % VIAFLO
Sponsors
Centre Hospitalier Regional Universitaire De Tours, Centre Hospitalier Universitaire De Dijon
Conditions
1st line treatment for unresectable metastatic colorectal canceracute pneumonianorepinephrine-refractory vasoplegic shock
Phase 3
Chimiothérapie à base de bevacizumab adaptée à la pharmacocinétique du bevacizumab en 1ère ligne de traitement du cancer colorectal métastatique non résécable : étude de phase 3 randomisée multicentrique en double aveugle.
RecruitingCTIS2023-507873-16-00
Start: 2025-03-04Target: 122Updated: 2024-08-19
ASPAPY - Aspirin in acute pneumonia in the elderly: a multicenter, double-blind, randomized, placebo-controlled trial
Not yet recruitingCTIS2024-510811-32-00
Target: 600Updated: 2025-09-10
Efficacy of early Argipressin (arginine vasopressin) in the management of intensive care patients with norepinephrine-refractory vasoplegic shock: a multicentric randomized, double-blind placebo-controlled superiority trial : Vaso²R
Not yet recruitingCTIS2024-516639-28-00
Target: 390Updated: 2026-01-14